Last update 23 Jan 2025

HMG-CoA reductase x SGLT2

Basic Info

Related Targets
HMG-CoA reductaseSGLT2

Related

1
Drugs associated with HMG-CoA reductase x SGLT2
Dapagliflozin/Rosuvastatin Calcium
Target
HMG-CoA reductase x SGLT2
Mechanism
HMG-CoA reductase inhibitors [+1]
Active Org.
CMG Pharmaceutical Co., Ltd.CMG Pharmaceutical Co., Ltd.
Originator Org.
CMG Pharmaceutical Co., Ltd.CMG Pharmaceutical Co., Ltd.
Active Indication
Diabetes Mellitus, Type 2 [+1]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with HMG-CoA reductase x SGLT2
NCT06772168
/ RecruitingPhase 3
A Multicenter, Randomized, Placebo-controlled, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of CMG190303 in Patients with Type 2 Diabetes and Dyslipidemia
100 Clinical Results associated with HMG-CoA reductase x SGLT2
Login to view more data
100 Translational Medicine associated with HMG-CoA reductase x SGLT2
Login to view more data
0 Patents (Medical) associated with HMG-CoA reductase x SGLT2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free